Audit data has exposed wide variation in prescribing of antiplatelet agents in patients with diabetes, with evidence of substantial underuse at some practices.
Whereas some practices in Gloucestershire had more than 90 per cent of eligible patients coded as receiving anti-platelets, in some the figure was under 50 per cent.
Dr Jonathan Bayly, clinical lead for the Gloucestershire Primary and Community Care Audit Group, said: 'The way to view this is seeing diabetes as a cardiovascular disease – this is only something that has recently drifted into the consciousness.
'The average general practitioner hasn't had the guidance that aspirin should be considered mandatory in these groups. We hope as we reaudit this to see improvement.'